CCN3 and Familial prostate cancer: Maillard et al. found that CCN3 was expressed predominantly in prostate cancer cell lines as well as the lymph node metastases compared with normal prostate epithelial cells [43], and similar results were obtained in cervical cancer, bone malignancies, and benign adrenocortical tumors [44–47].